162 related articles for article (PubMed ID: 3898672)
1. [Reactogenicity and antigenic activity of a chromatographic cultured purified and concentrated inactivated dried vaccine against tick-borne encephalitis].
Popov OV; Sumarokov AA; Shkol'nik RIa; El'bert LB; Vorob'eva MS
Zh Mikrobiol Epidemiol Immunobiol; 1985 Jun; (6):34-9. PubMed ID: 3898672
[TBL] [Abstract][Full Text] [Related]
2. [Reactogenicity and immunological effectiveness of a concentrated, purified vaccine against tick-borne encephalitis].
Vorob'eva MS; El'bert LB; Grachev VP; Lelikov VL; Pervikov IuV
Vopr Virusol; 1983; 28(5):622-6. PubMed ID: 6659477
[TBL] [Abstract][Full Text] [Related]
3. [Isolation of split and whole-virion tick-borne encephalitis vaccines in an experiment and the characteristics of their immunogenic and antigenic properties].
Osipova EG; Solianik RG; Fedorov IuV; Tymchishin PN
Zh Mikrobiol Epidemiol Immunobiol; 1987 Aug; (8):50-3. PubMed ID: 3687295
[TBL] [Abstract][Full Text] [Related]
4. [A cultured concentrated inactivated vaccine against tick-borne encephalitis studied during the immunization of children and adolescents].
Pavlova LI; Gorbunov MA; Vorob'eva MS; Karavanov AS; Grachev VP; Ladyshenskaia IP; Rasshchepkina MN; Mel'nikova LN; Lebedeva TM; Mel'nikov NA; Gusmanova AG; Deviatkov MIu; Rozanova EV; Mukachev MA
Zh Mikrobiol Epidemiol Immunobiol; 1999; (6):50-3. PubMed ID: 10876850
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and reactogenicity of a highly purified vaccine against tick-borne encephalitis.
Kunz C; Heinz FX; Hofmann H
J Med Virol; 1980; 6(2):103-9. PubMed ID: 7241091
[TBL] [Abstract][Full Text] [Related]
6. [Donor immunization with an inactivated concentrated purified vaccine against tick-borne encephalitis to obtain immune blood preparations].
El'bert LB; Pervikov IuV; Grachev VP; Rusanov VM; Krokhina MA
Vopr Virusol; 1984; 29(1):56-9. PubMed ID: 6608828
[TBL] [Abstract][Full Text] [Related]
7. [Immunological indices of human vaccination against tick-borne encephalitis using inactivated preparations with a varying concentration of the viral antigen].
El'bert LB; Pervikov IuV; Krutianskaia GL; Krasil'nikov IV; Grachev VP
Zh Mikrobiol Epidemiol Immunobiol; 1981 Jun; (6):89-92. PubMed ID: 7293574
[TBL] [Abstract][Full Text] [Related]
8. [Comparative study of inactivated cultured vaccines against tick-borne encephalitis manufactured in Russia and in Austria by the "Immuno" firm].
Vorob'eva MS; Rasshchepkina MN; Ladyzhenskaia IP; Gorbunov MA; Pavlova LI; Bektimirov TA
Vopr Virusol; 1996; 41(5):221-4. PubMed ID: 8967069
[TBL] [Abstract][Full Text] [Related]
9. [A new prospective vaccine against tick-borne encephalitis].
Chumakov MP; Rubin SG; Semashko IV; Karavanov AS; Avdeeva LI; Gagarina AV; Gambarian AS; Matrosovich MN; Mart'ianova LI; Mironova LL
Zh Mikrobiol Epidemiol Immunobiol; 1991 Jan; (1):36-40. PubMed ID: 1858468
[No Abstract] [Full Text] [Related]
10. Protection against European isolates of tick-borne encephalitis virus after vaccination with a new tick-borne encephalitis vaccine.
Klockmann U; Krivanec K; Stephenson JR; Hilfenhaus J
Vaccine; 1991 Mar; 9(3):210-2. PubMed ID: 2042394
[TBL] [Abstract][Full Text] [Related]
11. Stable and Highly Immunogenic MicroRNA-Targeted Single-Dose Live Attenuated Vaccine Candidate against Tick-Borne Encephalitis Constructed Using Genetic Backbone of Langat Virus.
Tsetsarkin KA; Maximova OA; Liu G; Kenney H; Teterina NL; Pletnev AG
mBio; 2019 Apr; 10(2):. PubMed ID: 31015334
[TBL] [Abstract][Full Text] [Related]
12. [Immunological status of people inoculated with various types of inactivated vaccine against tick-borne encephalitis].
Pervikov IuV; El'bert LB; Krutianskaia GL; Belotskiĭ SM; Krasil'nikov IV
Vopr Virusol; 1982; 27(6):696-701. PubMed ID: 7157778
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity against Far Eastern and Siberian subtypes of tick-borne encephalitis (TBE) virus elicited by the currently available vaccines based on the European subtype: systematic review and meta-analysis.
Domnich A; Panatto D; Arbuzova EK; Signori A; Avio U; Gasparini R; Amicizia D
Hum Vaccin Immunother; 2014; 10(10):2819-33. PubMed ID: 25483679
[TBL] [Abstract][Full Text] [Related]
14. [An assessment of the immunoepidemiological efficacy of a liquid cultured killed vaccine against tick-borne encephalitis virus strain 205 in the Maritime Territory].
Leonova GN; Liubimova NB; Sergeev GA; Muratkina SM; Krugliak SP; Bobkov AV; Bondarenko SI; Tutubalina GN; Beliaev MM
Zh Mikrobiol Epidemiol Immunobiol; 1992 Feb; (2):43-6. PubMed ID: 1441813
[TBL] [Abstract][Full Text] [Related]
15. [Use of inbred mice for assessing the neurovirulence of strains of the tick-borne encephalitis virus complex and the immunogenicity of a concentrated tick-borne encephalitis vaccine].
Kan GA; Borsuk EA; Vorob'eva MS
Vopr Virusol; 1982; 27(4):461-4. PubMed ID: 7135927
[TBL] [Abstract][Full Text] [Related]
16. [Clinico-immunological study of the effectiveness of vaccination against tick-borne encephalitis in the Maritime Territory].
Leonova GN; Krugliak SP; Stepanova NM; Gorelikov VN
Vopr Virusol; 1987; 32(2):225-8. PubMed ID: 3604187
[TBL] [Abstract][Full Text] [Related]
17. [Vaccination against tick-borne encephalitis using the Soviet liquid inactivated vaccine].
Plesník V; Januska J; Matuska J
Cesk Epidemiol Mikrobiol Imunol; 1984 Nov; 33(6):338-45. PubMed ID: 6239701
[No Abstract] [Full Text] [Related]
18. [Use of direct solid-phase immunoenzyme analysis for assessing the immunological activity of a vaccine against tick-borne encephalitis].
Timofeev AV; El'bert LB; Terletskaia EN; Mal'dov DG; Karavanov AS
Zh Mikrobiol Epidemiol Immunobiol; 1987 Sep; (9):89-93. PubMed ID: 3318250
[TBL] [Abstract][Full Text] [Related]
19. [Quantitative indices of the immune status of persons inoculated with different vaccines against tick-borne encephalitis].
Bukovskaia SN; Vorob'eva MS; Karpovich LG; Shalamberidze TD
Vopr Virusol; 1983; 28(4):100-3. PubMed ID: 6636697
[TBL] [Abstract][Full Text] [Related]
20. Randomized, phase II dose-finding studies of a modified tick-borne encephalitis vaccine: evaluation of safety and immunogenicity.
Ehrlich HJ; Pavlova BG; Fritsch S; Poellabauer EM; Loew-Baselli A; Obermann-Slupetzky O; Maritsch F; Cil I; Dorner F; Barrett PN
Vaccine; 2003 Dec; 22(2):217-23. PubMed ID: 14615149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
